All articles by Eloise Mclennan

  1. Pharma Technology Focus: the absence of antivenom in pharma

    Pharma Technology Focus is now available on all devices. Read it for free here Following the news that the UK BioIndustry…
    Read More…

    21 Mar
  2. Pharma Technology Focus: Scottish pharma gets a health check

    Pharma Technology Focus is now available on all devices. Read it for free here In July last year, the supply of…
    Read More…

    20 Feb
  3. Find out how pharma is fighting respiratory illnesses in the latest Pharma Technology Focus

    Pharma Technology Focus is now available on all devices. Read it for free here We look into the safety issues associated…
    Read More…

    31 Jan
  4. Find out about the foundation for the first drugs using microbiome bacteria in the latest issue of Pharma Technology Focus

    Pharma Technology Focus is now available on all devices. Read it for free here. In this issue we find out…
    Read More…

    19 Dec
  5. Pharma Technology Focus – Issue 77

    Pharma Technology Focus is now available on all devices. Read it for free here The top pharmaceutical companies have been…
    Read More…

    21 Nov
  6. Pharma Technology Focus – Issue 76

    Pharma Technology Focus is now available on all devices. Read it for free here Significant progress has been made to roll…
    Read More…

    25 Oct
  7. Pharma Technology Focus – Special Issue

    Pharma Technology Focus is now available on all devices. Read it for free here. Personalised medicine has been hailed as a…
    Read More…

    28 Sep
  8. Pharma Technology Focus – Issue 75

    Pharma Technology Focus is now available on all devices. Read it for free here. Researchers from the University of Toronto have…
    Read More…

    20 Sep
  9. Pharma Technology Focus – Issue 74

    Pharma Technology Focus is now available on all devices. Read it for free here. Trust in big pharma has never…
    Read More…

    23 Aug
  10. Pharma Technology Focus – Issue 73

    Pharma Technology Focus is now available on all devices. Read it for free here. Genentech has signed a $1bn open-ended drug…
    Read More…

    19 Jul

Go Top